Universal H1N1 influenza vaccine development

References

• Centers for Disease Control and Prevention. 2012-2013 Influenza Season Week 8 ending February 23, 2013. Centers for Disease Control and Prevention. Retrieved from: http://www.cdc.gov/flu/weekly/.
   Google Scholar
• Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. [Erratum in: Lancet Infect Dis 2012; 12:655; PMID:22032844; 10.1016/S1473-3099] [11] [70295-X] Lancet Infect Dis 2012; 12:36 - 44; http://dx.doi.org/10.1016/S1473-3099(11)70295-X; PMID: 22032844
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009; 58:521 - 4; PMID: 19478718
   PubMedGoogle Scholar
• De Groot AS, Ardito M, McClaine EM, Moise L, Martin WD. Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine. Vaccine 2009; 27:5740 - 7; http://dx.doi.org/10.1016/j.vaccine.2009.07.040; PMID: 19660593
   PubMed Web of Science ®Google Scholar
• Schanen BC, De Groot AS, Moise L, Ardito M, McClaine E, Martin W, et al. Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4(+) T cells against the swine-origin H1N1 influenza virus. Vaccine 2011; 29:3299 - 309; http://dx.doi.org/10.1016/j.vaccine.2011.02.019; PMID: 21349362
   PubMed Web of Science ®Google Scholar
• Koita OA, Dabitao D, Mahamadou I, Tall M, Dao S, Tounkara A, et al. Confirmation of immunogenic consensus sequence HIV-1 T-cell epitopes in Bamako, Mali and Providence, Rhode Island. Hum Vaccin 2006; 2:119 - 28; PMID: 17012903
   PubMed Web of Science ®Google Scholar
• De Groot AS, Bishop EA, Khan B, Lally M, Marcon L, Franco J, et al. Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine. Methods 2004; 34:476 - 87; http://dx.doi.org/10.1016/j.ymeth.2004.06.003; PMID: 15542374
   PubMed Web of Science ®Google Scholar
• Vita R, Zarebski L, Greenbaum JA, Emami H, Hoof I, Salimi N, et al. The immune epitope database 2.0. Nucleic Acids Res 2010; 38:Database issue D854 - 62; http://dx.doi.org/10.1093/nar/gkp1004; PMID: 19906713
   PubMed Web of Science ®Google Scholar
• Moise L, Gutierrez AH, Bailey-Kellogg C, Terry F, Leng Q, Abdel Hady KM, et al. The two-faced T cell epitope: Examining the host-microbe interface with JanusMatrix. Hum Vaccin Immunother 2013; 9; In press http://dx.doi.org/10.4161/hv.24615; PMID: 23584251
   PubMed Web of Science ®Google Scholar
• De Groot AS, Ardito M, Moise L, Gustafson EA, Spero D, Tejada G, et al. Immunogenic consensus sequence T helper epitopes for a pan-Burkholderia biodefense vaccine. Immunome Res 2011; 7:7; PMID: 22130150
   PubMedGoogle Scholar
• Moise L, McMurry JA, Pappo J, Lee DS, Moss SF, Martin WD, et al. Identification of genome-derived vaccine candidates conserved between human and mouse-adapted strains of H. pylori. Hum Vaccin 2008; 4:219 - 23; http://dx.doi.org/10.4161/hv.4.3.5394; PMID: 18376134
   PubMed Web of Science ®Google Scholar
• De Groot AS, Martin W. Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeutics. Clin Immunol 2009; 131:189 - 201; http://dx.doi.org/10.1016/j.clim.2009.01.009; PMID: 19269256
   PubMed Web of Science ®Google Scholar
• Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:1945 - 52; http://dx.doi.org/10.1056/NEJMoa0906453; PMID: 19745214
   PubMed Web of Science ®Google Scholar
• Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al, 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361:1935 - 44; http://dx.doi.org/10.1056/NEJMoa0906695; PMID: 19815859
   PubMed Web of Science ®Google Scholar
• Greenbaum JA, Kotturi MF, Kim Y, Oseroff C, Vaughan K, Salimi N, et al. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A 2009; 106:20365 - 70; http://dx.doi.org/10.1073/pnas.0911580106; PMID: 19918065
   PubMed Web of Science ®Google Scholar
• Richards KA, Topham D, Chaves FA, Sant AJ. Cutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus. J Immunol 2010; 185:4998 - 5002; http://dx.doi.org/10.4049/jimmunol.1001395; PMID: 20889549
   PubMed Web of Science ®Google Scholar
• Tu W, Mao H, Zheng J, Liu Y, Chiu SS, Qin G, et al. Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J Virol 2010; 84:6527 - 35; http://dx.doi.org/10.1128/JVI.00519-10; PMID: 20410263
   PubMed Web of Science ®Google Scholar
• Boon AC, de Mutsert G, van Baarle D, Smith DJ, Lapedes AS, Fouchier RA, et al. Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes. J Immunol 2004; 172:2453 - 60; PMID: 14764717
   PubMed Web of Science ®Google Scholar
• Kreijtz JH, Bodewes R, van Amerongen G, Kuiken T, Fouchier RA, Osterhaus AD, et al. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. Vaccine 2007; 25:612 - 20; http://dx.doi.org/10.1016/j.vaccine.2006.08.036; PMID: 17005299
   PubMed Web of Science ®Google Scholar
• Ge X, Tan V, Bollyky PL, Standifer NE, James EA, Kwok WW. Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus. J Virol 2010; 84:3312 - 9; http://dx.doi.org/10.1128/JVI.02226-09; PMID: 20071564
   PubMed Web of Science ®Google Scholar
• Ellebedy AH, Ducatez MF, Duan S, Stigger-Rosser E, Rubrum AM, Govorkova EA, et al. Impact of prior seasonal influenza vaccination and infection on pandemic A (H1N1) influenza virus replication in ferrets. Vaccine 2011; 29:3335 - 9; http://dx.doi.org/10.1016/j.vaccine.2010.08.067; PMID: 20840835
   PubMed Web of Science ®Google Scholar
• Garcia-Garcia L, Valdespino-Gómez JL, Lazcano-Ponce E, Jimenez-Corona A, Higuera-Iglesias A, Cruz-Hervert P, et al. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ 2009; 339:b3928; http://dx.doi.org/10.1136/bmj.b3928; PMID: 19808768
   PubMedGoogle Scholar
• Powell TJ, Peng Y, Berthoud TK, Blais ME, Lillie PJ, Hill AV, et al. Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine. PLoS One 2013; 8:e62778; http://dx.doi.org/10.1371/journal.pone.0062778; PMID: 23658773
   PubMed Web of Science ®Google Scholar
• Kamperschroer C, Dibble JP, Meents DL, Schwartzberg PL, Swain SL. SAP is required for Th cell function and for immunity to influenza. J Immunol 2006; 177:5317 - 27; PMID: 17015717
   PubMed Web of Science ®Google Scholar
• Belz GT, Wodarz D, Diaz G, Nowak MA, Doherty PC. Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice. J Virol 2002; 76:12388 - 93; http://dx.doi.org/10.1128/JVI.76.23.12388-12393.2002; PMID: 12414983
   PubMed Web of Science ®Google Scholar
• Cardin RD, Brooks JW, Sarawar SR, Doherty PC. Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. J Exp Med 1996; 184:863 - 71; http://dx.doi.org/10.1084/jem.184.3.863; PMID: 9064346
   PubMed Web of Science ®Google Scholar
• Brooks JW, Hamilton-Easton AM, Christensen JP, Cardin RD, Hardy CL, Doherty PC. Requirement for CD40 ligand, CD4(+) T cells, and B cells in an infectious mononucleosis-like syndrome. J Virol 1999; 73:9650 - 4; PMID: 10516078
   PubMed Web of Science ®Google Scholar
• Marshall D, Sealy R, Sangster M, Coleclough C. TH cells primed during influenza virus infection provide help for qualitatively distinct antibody responses to subsequent immunization. J Immunol 1999; 163:4673 - 82; PMID: 10528164
   PubMed Web of Science ®Google Scholar
• Lee LY, Ha LA, Simmons C, de Jong MD, Chau NV, Schumacher R, et al. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 2008; 118:3478 - 90; PMID: 18802496
   PubMed Web of Science ®Google Scholar
• Townsend AR, Skehel JJ. The influenza A virus nucleoprotein gene controls the induction of both subtype specific and cross-reactive cytotoxic T cells. J Exp Med 1984; 160:552 - 63; http://dx.doi.org/10.1084/jem.160.2.552; PMID: 6206181
   PubMed Web of Science ®Google Scholar
• Assarsson E, Bui HH, Sidney J, Zhang Q, Glenn J, Oseroff C, et al. Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans. J Virol 2008; 82:12241 - 51; http://dx.doi.org/10.1128/JVI.01563-08; PMID: 18842709
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, Kleppinger A, et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 2006; 176:6333 - 9; PMID: 16670345
   PubMed Web of Science ®Google Scholar
• Levitz L, Koita OA, Sangare K, Ardito MT, Boyle CM, Rozehnal J, et al. Conservation of HIV-1 T cell epitopes across time and clades: validation of immunogenic HLA-A2 epitopes selected for the GAIA HIV vaccine. Vaccine 2012; 30:7547 - 60; http://dx.doi.org/10.1016/j.vaccine.2012.10.042; PMID: 23102976
   PubMed Web of Science ®Google Scholar
• De Groot AS, Levitz L, Ardito MT, Skowron G, Mayer KH, Buus S, et al. Further progress on defining highly conserved immunogenic epitopes for a global HIV vaccine: HLA-A3-restricted GAIA vaccine epitopes. Hum Vaccin Immunother 2012; 8:987 - 1000; http://dx.doi.org/10.4161/hv.20528; PMID: 22777092
   PubMed Web of Science ®Google Scholar
• De Groot AS, Rivera DS, McMurry JA, Buus S, Martin W. Identification of immunogenic HLA-B7 “Achilles’ heel” epitopes within highly conserved regions of HIV. Vaccine 2008; 26:3059 - 71; http://dx.doi.org/10.1016/j.vaccine.2007.12.004; PMID: 18206276
   PubMedGoogle Scholar
• De Groot AS, Ardito M, Terry F, Levitz L, Ross TM, Moise L, et al. Low immunogenicity predicted for emerging avian-origin H7N9: Implication for influenza vaccine design. Hum Vaccin Immunother 2013; 9; In press http://dx.doi.org/10.4161/hv.24939; PMID: 23807079
   PubMed Web of Science ®Google Scholar
• Elfaki ME, Khalil EA, Degroot AS, Musa AM, Gutiérrez Núñez A, Younis BM, et al. Immunogenicity and immune modulatory effects of in silico predicted L. donovani candidate peptide vaccines. Hum Vaccin Immunother 2012; 8:1769 - 74; http://dx.doi.org/10.4161/hv.21881; PMID: 22922767
   PubMed Web of Science ®Google Scholar
• Poland GA. Vaccines against Lyme disease: What happened and what lessons can we learn?. Clin Infect Dis 2011; 52:Suppl 3 s253 - 8; http://dx.doi.org/10.1093/cid/ciq116; PMID: 21217172
   PubMed Web of Science ®Google Scholar
• Squires RB, Noronha J, Hunt V, García-Sastre A, Macken C, Baumgarth N, et al. Influenza research database: an integrated bioinformatics resource for influenza research and surveillance. Influenza Other Respi Viruses 2012; 6:404 - 16; http://dx.doi.org/10.1111/j.1750-2659.2011.00331.x; PMID: 22260278
   PubMed Web of Science ®Google Scholar
• De Groot AS, Jesdale BM, Szu E, Schafer JR, Chicz RM, Deocampo G. An interactive Web site providing major histocompatibility ligand predictions: application to HIV research. AIDS Res Hum Retroviruses 1997; 13:529 - 31; http://dx.doi.org/10.1089/aid.1997.13.529; PMID: 9135870
   PubMed Web of Science ®Google Scholar
• Southwood S, Sidney J, Kondo A, del Guercio MF, Appella E, Hoffman S, et al. Several common HLA-DR types share largely overlapping peptide binding repertoires. J Immunol 1998; 160:3363 - 73; PMID: 9531296
   PubMed Web of Science ®Google Scholar
• Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss JA, et al, NIH HMP Working Group. The NIH Human Microbiome Project. Genome Res 2009; 19:2317 - 23; http://dx.doi.org/10.1101/gr.096651.109; PMID: 19819907
   PubMed Web of Science ®Google Scholar
• Chain PS, Grafham DV, Fulton RS, Fitzgerald MG, Hostetler J, Muzny D, et al, Genomic Standards Consortium Human Microbiome Project Jumpstart Consortium. Genomics. Genome project standards in a new era of sequencing. Science 2009; 326:236 - 7; http://dx.doi.org/10.1126/science.1180614; PMID: 19815760
   PubMed Web of Science ®Google Scholar
• Nelson KE, Weinstock GM, Highlander SK, Worley KC, Creasy HH, Wortman JR, et al, Human Microbiome Jumpstart Reference Strains Consortium. A catalog of reference genomes from the human microbiome. Science 2010; 328:994 - 9; http://dx.doi.org/10.1126/science.1183605; PMID: 20489017
   PubMed Web of Science ®Google Scholar
• Steere AC, Klitz W, Drouin EE, Falk BA, Kwok WW, Nepom GT, et al. Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide. J Exp Med 2006; 203:961 - 71; http://dx.doi.org/10.1084/jem.20052471; PMID: 16585267
   PubMed Web of Science ®Google Scholar